Lemme
The Lemme capsule contains Eriomin, a patented lemon extract made mainly of eriocitrin, which is one of the plant pigments that give lemons their color.
Although research on eriocitrin has found some potentially promising results, most studies have only been done on mice or rats. In 2022, the company that owns the patent of Eriomin funded a small clinical trial involving 45 people, concluding that those who took it over a 12-week period had lower blood glucose and higher GLP-1 than those who took a placebo. There have been no financially independent human trials of this extract.
The second patented ingredient in Kardashian’s GLP-1 supplement Supresa is a saffron extract. There is limited evidence to suggest that saffron can help people lose weight. In one 2010 study, funded by Supresa patent holder Inoreal Ltd, 30 slightly overweight women were given a saffron supplement daily for eight weeks, and 30 others received a placebo. The saffron group snacked less and lost slightly more weight than the placebo group.
The final ingredient in the gummy comes from blood oranges. The patented version in the Lemme supplement is called Morosil, and it contains an extract called Moro. A 2022 study, funded by the patent holder BioNap, found that participants who took the ingredient daily had lower BMIs after six months than those on a placebo. But importantly, they were also asked to exercise three times a week and eat a limited number of calories per day depending on their basal metabolic rate.
Brands are jumping on the GLP-1 trend
Kardashian’s product is one of many jumping on the GLP-1 hype as the list of health benefits the medication could deliver grows longer and longer.
Weight loss and calorie-tracking app Noom has been quietly prescribing GLP-1s since last year, and in December Weight Watchers launched its GLP-1 program, designed to support those on the medication.
Meanwhile, Nestle has gotten in on the action with a range of product drinks, powders, gummies, and chewable tablets aimed at people taking the weight loss drugs.